...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Additional Reports of Exempt Distribution

What are we missing where you can buy Zenith shares with exact same cusip share #)on the grey market at a 85% discount and private placements are constantly flowing through. What are they being told or fed by the insiders.  

I think if the current 11 trials  have  very very good results I don't see what not one of the BP collaborations doesn't turn to huge partnership,CVR  buyout, or royalty deal. One of the BP will want an advantage over the others , ??? I wonder close a deal is or maybe not

Share
New Message
Please login to post a reply